Chronic Sinusitis may Increase Risk of Certain Subtypes of Head and Neck Cancers

Chronic sinusitis-related inflammation and immunodeficiency play a role in the development of certain subtypes of head and neck cancers.

Chronic sinusitis may be involved in the cause of certain head and neck cancers (HNCs) due to immunodeficiency or inflammation. Sinusitis is a common inflammatory condition of the sinuses often caused by viral or bacterial infections. The condition is considered chronic when the episode persists longer than 12 weeks. The risk of specific HNCs among people with chronic sinusitis is largely unknown.

In a study published online by JAMA Otolaryngology-Head & Neck Surgery, Daniel C. Beachler, Ph.D., M.H.S., and Eric A. Engels, M.D., M.P.H., of the National Cancer Institute, Bethesda, Md., evaluated the associations of chronic sinusitis with subsequent head and neck cancer in an elderly population.

Outcome in Head and Neck Cancer may be Predicted by Genetic Diversity Within Tumors
Researchers reveal that a new measure of the variety of genetic mutations of cells within a tumor appears to predict treatment outcomes.

‘Chronic sinusitis was associated with risk of developing head and neck cancers, particularly nasopharyngeal cancer, human papillomavirus-related oropharyngeal cancer, and nasal cavity and paranasal sinus cancer.’

For this study, the researchers used the Surveillance, Epidemiology, and End Results (SEER)-Medicare database and included 483,546 Medicare beneficiaries from SEER areas in a 5 percent random subcohort, and 826,436 from the entire source population who developed cancer (including 21,716 with HNC).

Most individuals were female (58 percent), and the average age at entry was 73 years. Chronic sinusitis was associated with risk of developing HNC, particularly nasopharyngeal cancer (NPC), human papillomavirus-related oropharyngeal cancer (HPV-OPC), and nasal cavity and paranasal sinus cancer (NCPSC). Most of this increased risk was limited to risk within 1 year of the chronic sinusitis diagnosis, as associations were largely reduced 1 year or more after chronic sinusitis. All 3 HNC subtypes had cumulative incidence of less than 0.07 percent 8 years after chronic sinusitis diagnosis.

The authors write that these findings suggest that sinusitis-related inflammation and immunodeficiency play, at most, a minor role in the development of these cancers.

Safety-Net Hospitals: Surgical Outcomes After Head and Neck Cancer Examined
A report says that safety-net hospitals appear to provide head and neck cancer surgical care to a vulnerable population.

"Despite the fact that people with chronic sinusitis have an increased risk for certain subtypes of HNCs, the absolute risk of these cancers is low. The cumulative incidence of NPC, HPV-OPC, and NCPSC was less than 0.10 percent after 8 years of follow-up after a chronic sinusitis diagnosis. There are currently no general U.S. guidelines for HNC screening, but given the low absolute risk, our findings do not support a need for HNC screening in individuals with chronic sinusitis."

Research Sheds Light on Head and Neck Cancer in Transplant Patients
A new study from Henry Ford Hospital in Detroit has revealed that transplant patients who develop head and neck cancer are more likely to be non-smokers and non-drinkers.

Source-Eurekalert

Alterations in Head and Neck Cancer That Could Lead to Targeted Therapy Identified by Comprehensive Genomic Analysis
Head and neck cancers with certain distinctive patterns could be amenable to specific targeted therapies, according to a researcher.